Nova Patents
IL276289B

Therapeutic uses of empagliflozin

Abstract

This record has no abstract on file.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Published
  4. Today

72 members in 24 offices

This recordMember, by publication datePriority claim14 more offices are in the list below

Priority claims34

Priority claims
DocumentOfficeKindDate
201361808807United States of AmericaP
201361808807United States of AmericaP
61808807United States of America–
2812016CanadaA
2812016CanadaA
2812016Canada–
201361823041United States of AmericaP
201361823041United States of AmericaP
61823041United States of America–
201361835809United States of AmericaP
201361835809United States of AmericaP
201361835811United States of AmericaP
201361835811United States of AmericaP
61835809United States of America–
61835811United States of America–
201461942301United States of AmericaP
201461942301United States of AmericaP
61942301United States of America–
2014056655European Patent Office (EPO)W
2014056655European Patent Office (EPO)W
2812016–––
61808807–––
61823041–––
61835809–––
61835811–––
61942301–––
CA20132812016–––
PCTEP2014056655–––
US201361808807P–––
US201361823041P–––
US201361835809P–––
US201361835811P–––
US201461942301P–––
WO2014EP56655–––

Members72

Family members, oldest first
DocumentOfficeKind
CA2812016A1CanadaA1
CA2908621A1CanadaA1
US2014303097A1United States of AmericaA1
WO2014161918A1World Intellectual Property Organization (WIPO)A1
AU2014247091A1AustraliaA1
IL241101A0IsraelA0
IL241101D0IsraelD0
KR20150138859ARepublic of KoreaA
US2016000816A1United States of AmericaA1
CN105263485AChinaA
PH12015502276A1PhilippinesA1
PH12015502276B1PhilippinesB1
EP2981255A1European Patent Office (EPO)A1
US2016038523A1United States of AmericaA1
EA201500996A1Eurasian Patent Organization (EAPO)A1
JP2016515599AJapanA
HK1213818AHong Kong, ChinaA
HK1213818A1Hong Kong, ChinaA1
MX2015013948AMexicoA
CL2015002941A1ChileA1
US9949997B2United States of AmericaB2
JP6325084B2JapanB2
JP2018131448AJapanA
AU2014247091B2AustraliaB2
US2019015437A1United States of AmericaA1
US2019038654A1United States of AmericaA1
CN109512831AChinaA
AU2019202568A1AustraliaA1
CN110075301AChinaA
JP6672365B2JapanB2
EA035181B1Eurasian Patent Organization (EAPO)B1
JP2020109100AJapanA
JP2020109100AJapanA
IL276289AIsraelA
IL276289D0IsraelD0
IL241101AIsraelA
IL241101BIsraelB
US2020360412A1United States of AmericaA1
US2020368261A1United States of AmericaA1
NZ711659ANew ZealandA
PH12020500352A1PhilippinesA1
AU2019202568B2AustraliaB2
KR102318207B1Republic of KoreaB1
KR20210131442ARepublic of KoreaA
US2021346418A1United States of AmericaA1
IL287516AIsraelA
IL287516D0IsraelD0
IL276289BThis recordIsraelB
US2022110961A1United States of AmericaA1
JP2022069476AJapanA
CA2908621CCanadaC
EP2981255B1European Patent Office (EPO)B1
MX2020013740AMexicoA
DK2981255T3DenmarkT3
PT2981255TPortugalT
LT2981255TLithuaniaT
FI2981255T3FinlandT3
ES2930655T3SpainT3
RS63721B1SerbiaB1
HRP20221368T1CroatiaT1
PL2981255T3PolandT3
EP4119136A1European Patent Office (EPO)A1
HUE060721T2HungaryT2
KR20230074293ARepublic of KoreaA
IL287516B1IsraelB1
US11813275B2United States of AmericaB2
US11918596B2United States of AmericaB2
JP2024059725AJapanA
US2024156848A1United States of AmericaA1
JP7541641B2JapanB2
MX378422BMexicoB
US2025345352A1United States of AmericaA1